骨髓增殖性肿瘤女性的分娩率
研究基于瑞典医疗登记数据,纳入1973-2018年确诊的15-44岁骨髓增殖性肿瘤(MPN)女性1141例,并按1:4匹配4564例人群对照,描述生殖模式并量化流产与死产风险。结果显示MPN女性分娩率低于对照(HR 0.78,95%CI 0.68-0.90),但原发性血小板增多症无显著降低,而真性红细胞增多症和原发性骨髓纤维化显著降低;流产风险未显著增加。
要点
- MPN女性分娩率低于对照,HR 0.78(95%CI 0.68-0.90)。
- 原发性血小板增多症分娩率无显著降低,HR 1.02(95%CI 0.86-1.22)。
- 真性红细胞增多症和原发性骨髓纤维化分娩率显著降低,HR分别为0.50和0.45。
核心结论
- MPN女性分娩率低于对照,但原发性血小板增多症女性未见降低。
研究设计与样本
- 基于瑞典医疗登记数据的队列研究,纳入1973-2018年确诊的15-44岁MPN女性1141例,按年龄1:4匹配4564例人群对照。
主要发现
- MPN女性分娩率低于对照,HR 0.78(95%CI 0.68-0.90)。
- 亚组分析显示原发性血小板增多症分娩率未显著降低,HR 1.02(95%CI 0.86-1.22);真性红细胞增多症HR 0.50(95%CI 0.33-0.76);原发性骨髓纤维化HR 0.45(95%CI 0.28-0.74)。
- 诊断前流产风险未显著增加,诊断后随访期间HR 1.25(95%CI 0.89-1.76)。
- MPN女性更可能有既往死产史。
- MPN女性诊断时子女数更少,总子女数也更少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPN) are associated with inferior pregnancy outcome, however, little is known about fertility and childbearing potential in women with MPN. In this study we aimed to describe reproductive patterns, as well as to quantify risk of miscarriage and stillbirth. Women aged 15-44 years with an MPN diagnosis 1973-2018, were identified in Swedish health care registers, and age-matched 1:4 to population controls. We identified 1141 women with MPN and 4564 controls. Women with MPN had a lower rate of childbirth (hazard ratio [HR] with 95% confidence interval was 0.78 (0.68-0.90)). Subgroup analysis showed that the rate was not significantly reduced in essential thrombocythemia, HR 1.02 (0.86-1.22) while the HR was 0.50 (0.33-0.76) in PV and 0.45 (0.28-0.74) in PMF. The risk of miscarriage was not significantly increased before MPN diagnosis, the HR during follow-up after diagnosis was 1.25 (0.89-1.76). Women with MPN were more likely to have had a previous stillbirth. Women with MPN had fewer children at diagnosis, and fewer children in total. In conclusion, the childbirth rate was lower among women with MPN than controls, but not among women with essential thrombocythemia.
引用
- Landtblom AR, Andersson TM, Johansson ALV, et al. Childbirth rates in women with myeloproliferative neoplasms. Leukemia. 2024. PMID: 38461191. doi:10.1038/s41375-024-02216-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。